Terms: = Cervical cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS
82 results:
1. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
2. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
3. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
4. Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline
Yoshida H; Hiranuma K; Nakahara M; Kobayashi-Kato M; Tanase Y; Uno M; Shiraishi K; Ishikawa M; Kato T
Int J Surg Pathol; 2024 Apr; 32(2):394-400. PubMed ID: 37226494
[TBL] [Abstract] [Full Text] [Related]
5. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract] [Full Text] [Related]
6. AMPK-like proteins and their function in female reproduction and gynecologic cancer.
Baumgartner C; Yadav AK; Chefetz I
Adv Protein Chem Struct Biol; 2023; 134():245-270. PubMed ID: 36858738
[TBL] [Abstract] [Full Text] [Related]
7. Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.
Chakravarthy A; Reddin I; Henderson S; Dong C; Kirkwood N; Jeyakumar M; Rodriguez DR; Martinez NG; McDermott J; Su X; Egawa N; Fjeldbo CS; Skingen VE; Lyng H; Halle MK; Krakstad C; Soleiman A; Sprung S; Lechner M; Ellis PJI; Wass M; Michaelis M; Fiegl H; Salvesen H; Thomas GJ; Doorbar J; Chester K; Feber A; Fenton TR
Nat Commun; 2022 Oct; 13(1):5818. PubMed ID: 36207323
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic cervical cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
Xu Q; Wang J; Sun Y; Lin Y; Liu J; Zhuo Y; Huang Z; Huang S; Chen Y; Chen L; Ke M; Li L; Li Z; Pan J; Song Y; Liu R; Chen C
J Clin Oncol; 2022 Jun; 40(16):1795-1805. PubMed ID: 35192397
[TBL] [Abstract] [Full Text] [Related]
9. Gastric-type mucinous adenocarcinoma of the cervix in a woman with Peutz-Jeghers syndrome: a case report.
Tong T; Fan Q; Shi S; Li Y; Wang Y
Acta Chir Belg; 2023 Aug; 123(4):448-453. PubMed ID: 35135434
[TBL] [Abstract] [Full Text] [Related]
10. HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
Regauer S; Reich O; Kashofer K
Am J Surg Pathol; 2022 Feb; 46(2):147-158. PubMed ID: 34387215
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component.
Park E; Kim YT; Kim S; Nam EJ; Cho NH
Mod Pathol; 2021 Sep; 34(9):1738-1749. PubMed ID: 34103667
[TBL] [Abstract] [Full Text] [Related]
12. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
[TBL] [Abstract] [Full Text] [Related]
13. Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primary.
Rassy E; Boussios S; Pavlidis N
Eur J Clin Invest; 2021 Sep; 51(9):e13583. PubMed ID: 33970501
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive genomic profiling and prognostic analysis of cervical gastric-type mucinous adenocarcinoma.
Lu S; Shi J; Zhang X; Kong F; Liu L; Dong X; Wang K; Shen D
Virchows Arch; 2021 Nov; 479(5):893-903. PubMed ID: 33817764
[TBL] [Abstract] [Full Text] [Related]
15. Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
Selenica P; Alemar B; Matrai C; Talia KL; Veras E; Hussein Y; Oliva E; Beets-Tan RGH; Mikami Y; McCluggage WG; Kiyokawa T; Weigelt B; Park KJ; Murali R
Mod Pathol; 2021 Jun; 34(6):1213-1225. PubMed ID: 33318584
[TBL] [Abstract] [Full Text] [Related]
16. Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with
Jhaveri K; Chang MT; Juric D; Saura C; Gambardella V; Melnyk A; Patel MR; Ribrag V; Ma CX; Aljumaily R; Bedard PL; Sachdev JC; Dunn L; Won H; Bond J; Jones S; Savage HM; Scaltriti M; Wilson TR; Wei MC; Hyman DM
Clin Cancer Res; 2021 Jan; 27(2):447-459. PubMed ID: 33148674
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.
Jung H; Bae GE; Kim HM; Kim HS
Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
[TBL] [Abstract] [Full Text] [Related]
18. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
[TBL] [Abstract] [Full Text] [Related]
19. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
[TBL] [Abstract] [Full Text] [Related]
20. miR-106a Regulates Cell Proliferation and Autophagy by Targeting lkb1 in HPV-16-Associated cervical cancer.
Cui X; Wang X; Zhou X; Jia J; Chen H; Zhao W
Mol Cancer Res; 2020 Aug; 18(8):1129-1141. PubMed ID: 32345599
[TBL] [Abstract] [Full Text] [Related]
[Next]
